Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-09-24 Purchase(A) | 2026-09-28 5:01 pm | AtlasClear Holdings Inc. | ATCH | Patel Sandip I CFO & General Counsel | 100,000 | $0.2074 | $20,740 | 905,130 (Direct) | View |
| 2024-11-14 Sale | 2024-11-18 6:55 pm | Peak Bio Inc. | PKBO | Patel Sandip I Director | 947,306 | $0 | $0 | 0 (Indirect Direct) | View |
| 2024-02-09 Sale | 2024-02-16 7:13 pm | Quantum FinTech Acquisition Corp | QFTA | Patel Sandip I Director | 41,334 | $0 | $0 | 0 (Direct) | View |
| 2023-03-09 Sale | 2023-03-13 8:44 pm | Monterey Innovation Acquisition Corp | MTRY | Patel Sandip I Director 10% Owner | 570,000 | $0.006 | $3,420 | 1,527,500 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-10-14 Exercise | 2026-10-16 5:20 pm | N/A N/A | Akari Therapeutics Plc | AKTX | Patel Sandip I Director | 10,052 | $0.0004 | 98,877 (Direct) | View |
| 2026-08-18 Option Award | 2026-10-16 5:20 pm | N/A N/A | Akari Therapeutics Plc | AKTX | Patel Sandip I Director | 16,413 | $7.899 | 98,877 (Direct) | View |
| 2026-08-18 Option Award | 2026-10-16 5:20 pm | N/A 2036-08-18 | Akari Therapeutics Plc | AKTX | Patel Sandip I Director | 60,000 | $0 | 98,877 (Direct) | View |
| 2026-10-14 Exercise | 2026-10-16 5:20 pm | N/A N/A | Akari Therapeutics Plc | AKTX | Patel Sandip I Director | 10,052 | $16.16 | 98,877 (Direct) | View |
| 2026-10-01 Option Award | 2026-10-02 4:34 pm | N/A 2033-10-01 | AtlasClear Holdings Inc. | ATCH | Patel Sandip I CFO and General Counsel | 777,332 | $0 | 777,332 (Direct) | View |
| 2026-09-24 Option Award | 2026-09-28 09:26 am | N/A N/A | AtlasClear Holdings Inc. | ATCH | Patel Sandip I CFO & General Counsel | 50,000 | $0.2173 | 905,130 (Direct) | View |
| 2026-09-25 Option Award | 2026-09-28 09:26 am | N/A N/A | AtlasClear Holdings Inc. | ATCH | Patel Sandip I CFO & General Counsel | 50,000 | $0.1975 | 905,130 (Direct) | View |
| 2026-07-14 Option Award | 2026-07-16 8:21 pm | 2026-07-14 2030-01-26 | AtlasClear Holdings Inc. | ATCH | Patel Sandip I CFO and General Counsel | 776,030 | $0 | 776,030 (Direct) | View |
| 2025-03-06 Option Award | 2025-04-29 5:00 pm | 2025-03-06 2026-03-06 | Akari Therapeutics Plc | AKTX | Patel Sandip I Director | 89,284 | $1.12 | 646,033 (Direct) | View |
| 2025-03-20 Option Award | 2025-03-24 5:00 pm | N/A 2035-03-20 | Akari Therapeutics Plc | AKTX | Patel Sandip I Director | 400,000 | $0 | 912,107 (Direct) | View |
Ownership | 2024-11-22 4:30 pm | N/A N/A | Akari Therapeutics Plc | AKTX | Patel Sandip I Director | 0 | $0 | 1,259,014,000 (Direct) | View |
| 2024-11-14 Conversion | 2024-11-18 6:55 pm | N/A N/A | Peak Bio Inc. | PKBO | Patel Sandip I Director | 1,038,816 | $0 | 0 (Direct) | View |
| 2024-03-20 Other | 2024-04-16 5:26 pm | N/A N/A | AtlasClear Holdings Inc. | ATCH | Patel Sandip I Director | 555,948 | $0 | 799,142 (Direct) | View |
Ownership | 2024-04-16 5:24 pm | N/A N/A | AtlasClear Holdings Inc. | ATCH | Patel Sandip I Director | 0 | $0 | 41,334 (Direct) | View |
| 2023-03-09 Other | 2023-03-13 8:44 pm | N/A N/A | Monterey Innovation Acquisition Corp | MTRY | Patel Sandip I Director 10% Owner | 75,000 | $0 | 1,527,500 (Indirect) | View |